CAS 1361569-23-4

6-Amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-7,9-dimethyl-7,9-dihydro-8H-purin-8-one

CAS: 1361569-23-4

6-Amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-7,9-dimethyl-7,9-dihydro-8H-purin-8-one

Reinheit: 99%

Molekulargewicht: 404.41g/mol

Ref: 54-PC1006419

Guanylate cyclase-IN-1

CAS: 1361569-23-4

Guanylate cyclase-IN-1 (Example 46) is a specific inhibitor of guanylate cyclase, employed in research related to cardiovascular diseases.

Formel: C₂₀H₁₇FN₈O

Farbe und Form: Solid

Molekulargewicht: 404.409

Ref: TM-T38770

Riociguat Impurity 14

CAS: 1361569-23-4

Formel: C₂₀H₁₇FN₈O

Molekulargewicht: 404.41

Ref: 4Z-R-080019

6-Amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-7,9-dimethyl-7H-purin-8(9H)-one

CAS: 1361569-23-4

6-Amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-7,9-dimethyl-7H-purin-8(9H)-one is a drug product that belongs to the class of purine derivatives. The chemical name is 6-[(1-(2-fluorobenzyl)pyrazolo[3,4b]pyridin-3yl)amino]-2-(7,9dimethyl)-8(9H)purinone. It has been shown to be metabolized by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. This active form is also bound to markers expressed at high levels in Mycobacterium tuberculosis strains (e.g., ESX

Formel: C₂₀H₁₇FN₈O

Reinheit: Min. 95%

Molekulargewicht: 404.4 g/mol

Ref: 3D-LEC56923

Riociguat Impurity 19

CAS: 1361569-23-4

Formel: C₂₀H₁₇FN₈O

Molekulargewicht: 404.4

Ref: ST-EA-CP-R35017